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Abstract. Stroke is the third highest cerebrovascular disease in the world with high mortality 
and disability rate that is mostly dominated by ischemic stroke. Genetic factor that had been 
reported to have an indirect effect in increasing the incidence of ischemic stroke is ACE gene 
polymorphism. ACE gene polymorphism is characterized by the insertion marked by letter 
(I) or deletion marked by letter (D) on intron 16, chromosome 17. ACE gene polymorphism 
has drawn a lot of attention from scientists and had been reported to have an indirect effect 
in increasing the ischemic stroke incidence through pathogenesis of  hypertension and 
atherosclerosis. In this study, 78 subjects of ischemic stroke consist of 43 subjects with 
hypertension and 35 subjects with normotension. I allele of ACE gene polymorphism was 
more dominant than D allele in hypertensive ischemic stroke patients (72.1% > 27,9%), and 
this dominance was also seen in the incidence of hypertension vs normotension (55.4% > 
44.6%).  However,  the correlation of  ACE  gene polymorphism with the incidence of 
hypertension was not statistically significant when compared based on its genotype (p=0.280) 
and allele (p=0.948). 
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1.   Introduction 
 
Stroke is the second most killer in the world and causes more than five million deaths per year, and 
more than three and a half is dominated by ischemic stroke [1][2]. Based on the International 
Classification of Disease (ICD)-11 in WHO, ischemic stroke is defined as an acute partial 
neurological dysfunction in one or several parts of the brain. Ischemic stroke can be diagnosed if 
the duration of symptoms lasts more than 24 hours or by neuroimaging of the brain [3]. The main 
causes of ischemic stroke are hypertension, and the presence of plaque in the arteries called 
atherosclerosis [4]. 
 
In previous studies, genetic factors have been known to be involved in the occurrence of 
ischemic stroke. Genetic factors such as ACE gene polymorphism may influence by 
modulating other 
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ischemic stroke risk factors, such as hypertension [5][6]. The ACE gene polymorphism was first 
discovered by Rigat et al. in 1990 and this gene located on the long arm of chromosome 17 at 
position 23.3 that consists of 26 exons and 25 introns [7][8]. The ACE gene polymorphism was 
marked by insertion (I allele) or deletion (D allele) at 287 base pairs (bp) on intron 16, which 
results in three different types of genotypes: II, ID and DD. Identification of intron 16 from the 
ACE gene resulted in a PCR product of 490 bp for I allele or 190 bp for D allele [8][9]. 
 
In the renin-angiotensin-aldosterone system, ACE has an important role in vascular remodelling, 
the formation of atherosclerosis and hypertension, which results in stroke. D allele can directly 
affect the risk of stroke by influencing other factors, such as vascular endothelium modification 
[10]. DD genotypes have an increased risk of ischemic stroke. However, many genetic and 
environmental risk factors may contribute to this complex condition [11]. 
 
In 2011, a research conducted in Yogyakarta found that the frequencies of DD genotype and D 
allele of the ACE gene polymorphism were higher in the hypertension group compared to 
normotension. Therefore, there was a correlation between ACE gene polymorphism and 
hypertension [12][13]. On the contrary, in 2017, there was no significant correlation between ACE 
gene polymorphism and hypertension in ischemic stroke patients [14]. 
 
In this study, it is proposed to determine the correlation between ACE gene polymorphism and 
hypertension in ischemic stroke patients in North Sumatra, that has never been done before. The 
results of this study are expected to provide education, the information in therapy and prognosis 
to patients. 
 
 
2.   Materials and Methods 
 
2.1.    Place and Year Work 
 
The present study was carried out from July – September 2019. The ACE genes were obtained 
and approved by previous researcher Arina et al., [15]. The determination of PCR products from 
ACE gene polymorphism was carried out in Integrated Laboratory from the Department of 
Biomedical Science, Faculty of Medicine, Universitas Sumatera Utara. 
 
2.2.    Ethics Statement 
 
The research was approved by The Health Research Ethical Committee of Faculty of Medicine, 
Universitas Sumatera Utara. Written informed consent was obtained prior to the investigation. 
 
2.3.    Subjects 
 
The study included a total of 78 stroke ischemic patients of both sexes, consisting of 43 
hypertensive patients and 35 normotensive patients. Each individual was recruited form the 
General Hospital H. Adam Malik, North Sumatra, Indonesia. Inclusion criteria include the 
admission of stroke ischemic patient at age > 18 years old; the neurological deficits were 
confirmed in all cases by computerized tomography (CT) scan [15].
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2.4.    DNA Studies 
 
The genotype of the ACE gene was determined by the polymerase chain reaction (PCR) using 
Thermal Cycler. The total volume of 25 μL PCR tube was used, consisting of 2 μL isolated DNA, 
 
12.5 μL GoTaq® Green Master Mix, 1 μL forward primer, 1 μL reverse primer and 8.5 μL 
nuclease-free water. The ACE gene in DNA samples was amplified with an initial denaturation 
temperature of 95⁰C for 1 minute, and continued with 32 cycles consisting of denaturation at 95⁰C 
for 30 seconds, annealing at 59⁰C for 60 seconds and extension at extension 72⁰C for 90 seconds 
with final extension for 5 minutes. The PCR products were analyzed on a 2% agarose gels, stained 
with ethidium bromide and 50 bp DNA Ladder (Promega), showed one band of 490 bp 
corresponding to the homozygous (II), two bands of 190, and 490 bp for the heterozygous (ID), 
one band of 190 bp for the homozygous (DD). All DD genotypes were reamplified in order to 
avoid the probability of mistyping ID heterozygotes as DD homozygotes by using new primer 
sense specific for the insertion, and the result was negative. 
 
2.5.    Statistical Analysis 
 
The values of the data on clinical characteristics of the subject groups were expressed in 
percentages. Allele and genotype frequencies in ischemic stroke subjects with history of 
hypertension and normotension were analysed using chi-square and Fisher exact test. All statistical 
analysis was performed using Statistical Package for Social Sciences (SPSS) version 
25. 
 
 
 
3.   Results 
 
The characteristics of the 43 hypertensive and 35 normotensive of stroke ischemic patients who 
met the criteria are summarized in Table 1. In this study, both of 39 men and women had an 
ischemic stroke, 33 patients at the age below 55 y.o, while 45 patients at the age above 55 y.o. 
 
 
Table 1  Distribution of characteristic frequency ischemic stroke patients with 
hypertension and normotension 
 
Ischemic Stroke
Variable     Category Hypertension             Normotension              Total
 
 N % N % N % 
Gender Male 21 26.9 18 23.1 39 50 
 Female 22 28.2 17 21.8 39 50 
Age ≤ 55 y.o 16 20.5 17 21.8 33 42.3 
 > 55 y.o 27 34.6 18 23.1 45 57.7 
 
 
The distribution of stroke ischemic subjects based on genotype and allele are presented in Table 
 
2. In this study, the majority of the subjects are distributed by the presence of I allele.
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Table 2  Distribution of ACE gene polymorphism in ischemic stroke patients based on 
genotype and allele 
 
ACE gene polymorphism Category N=78 (%) 
Genotype II 43 55.1 
 ID 27 34.6 
 DD 8 10.3 
Allele I (Insertion) 56 71.8 
 D (Deletion) 22 28.2 
 
 
 
Polymorphism was detected as a 490 bp PCR product corresponding to the insertion allele (I) and 
 
190 bp corresponding to the deletion allele (D). Genotype and allele frequencies are shown in 
Table 3. Among 78 ischemic stroke patients with hypertension and normotension, the II genotype 
was found in 43 patients; 55.1% (25 patients with hypertension, 18 patients with normotension). 
The ID genotype was found in 27 patients; 34.6% (12 patients with hypertension, 15 patients with 
normotension). The DD genotype was found in 8 patients; 10.3% (6 patients with hypertension 
and 2 patients with normotension). Based on the allele, I allele was found in 56 patients; 71.8% 
(31 patients with hypertension, 25 patients with normotension). The D allele was found in 22 
patients; 28.2% (12 patients with hypertension, 10 patients with normotension). Fisher exact test 
was done for genotype (p = 0.280), and chi-square was done for allele (p = 0.948), the results 
showed that the correlation was not significant respectively. 
 
 
Table 3  Distribution of ACE gene polymorphism in ischemic stroke patients with 
                                 hypertension and normotension based on genotype and allele  
 
ACE gene 
polymorphism        
Category Ischemic Stroke P 
valaue Hypertension Normotension Total 
F % F % F % 
Genotype II 25 32 18 23.1 43 55.1 0.280* 
 ID 12 15.4 15 19.2 27 34.6 
 DD 6 7.7 2 2.6 8 10.3 
Allele I 31 39.7 25 32.1 56 71.8 0.948** 
D 12 15.4 10 12.8 22 28.2 
*Fisher Exact Test;  **Chi-square Test
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Figure 1   Electrophoresis results of ACE gene polymorphism on 2% agarose 
gel (samples number 34-50) 
 
 
4.   Discussion 
 
The distribution of ACE gene polymorphism is still varied among several ethnicities in the world. 
In the study of Heidari et al., the distributions of ACE I/D polymorphism in Asians and other 
populations were differences between each other [16]. Studies of ACE gene polymorphism on 
homogeneous populations are expected in future studies. 
 
In He et al. analysis, the II genotypes seen to have the highest ACE activities, but not in agreement 
with majority of the researchers [17]. Many studies have shown that D allele carrier has high 
plasma ACE level that lead to hypertension [6][8][18]. The study of Ljungberg et al. did not 
support that the ACE level associated with hypertension both in men and women. There was no 
correlation between ACE level and systolic, diastolic and pulse pressure as well [19]. However, 
Rasyid et al. found a significant correlation of ACE I/D polymorphism with pulse pressure [9]. 
 
Our analysis showed that both hypertension and normotension subjects, II carriers were highest 
frequencies followed by ID and lowest were DD. Based on DD genotype, the ratio between both 
subjects was 3:1 for hypertension. The distribution of the alleles in subjects was showed not much 
difference between the two groups. Hence, there was no difference between ACE gene 
polymorphism and hypertension in ischemic stroke population, and this result was consistent with 
Indrajaya’s and Shaleh’s [5][14]. There were more negative than positive studies from the effect 
of ACE gene in relation to ischemic stroke [7]. According to Indrajaya, ACE gene plays a role of 
around 5% in the development of ischemic stroke [5]. In 2017, study of Malueka et al. showed 
significant correlation between ACE gene polymorphism and ischemic stroke by measuring the 
functional outcome [20]. 
 
Inconsistencies were still visible between researchers about the ACE gene polymorphism in 
ischemic stroke patients. Therefore, further studies are still needed, for example, the relationship 
to other factors such as gene or protein expression that plays role in the process of atherosclerosis 
that lead to ischemic stroke.
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5.   Conclusion 
 
Based on the allele and its genotype, there is no significant correlation between ACE gene 
polymorphism and hypertension in ischemic stroke patients. In this study, majority of the subjects 
are dominated by I allele. 
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